What happened
HEM Pharma updated the terms of convertible bonds to raise US$10.3M, about 6.6% of its market value.
For context, this raise equals about 6.6% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$10.3M |
| vs. market value | 6.6% |
| Filed | 2026-06-19, [Amended] Material event report (convertible bonds) |
| Source | DART rcept 20260619000658 → open original filing |
Source: DART. Information only, not investment advice.